8MV0 Stock Overview
Operates as a biotechnology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BioHarvest Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$5.68 |
| 52 Week High | CA$7.00 |
| 52 Week Low | CA$4.01 |
| Beta | 1.61 |
| 1 Month Change | -0.35% |
| 3 Month Change | 18.70% |
| 1 Year Change | 15.10% |
| 3 Year Change | -43.65% |
| 5 Year Change | n/a |
| Change since IPO | 70.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8MV0 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -2.1% | -1.8% | -2.0% |
| 1Y | 15.1% | -7.7% | 6.9% |
Return vs Industry: 8MV0 exceeded the German Personal Products industry which returned -7.7% over the past year.
Return vs Market: 8MV0 exceeded the German Market which returned 6.9% over the past year.
Price Volatility
| 8MV0 volatility | |
|---|---|
| 8MV0 Average Weekly Movement | 7.0% |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8MV0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 8MV0's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ilan Sobel | www.bioharvest.com |
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.
BioHarvest Sciences Inc. Fundamentals Summary
| 8MV0 fundamental statistics | |
|---|---|
| Market cap | €101.61m |
| Earnings (TTM) | -€16.52m |
| Revenue (TTM) | €21.55m |
4.7x
P/S Ratio-6.2x
P/E RatioIs 8MV0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8MV0 income statement (TTM) | |
|---|---|
| Revenue | US$22.43m |
| Cost of Revenue | US$10.32m |
| Gross Profit | US$12.11m |
| Other Expenses | US$29.30m |
| Earnings | -US$17.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.99 |
| Gross Margin | 54.00% |
| Net Profit Margin | -76.65% |
| Debt/Equity Ratio | 28.8% |
How did 8MV0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 01:41 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioHarvest Sciences Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hunter Diamond | Diamond Equity Research LLC |
| Amit Dayal | H.C. Wainwright & Co. |
| Anthony Vendetti | Maxim Group |